文献速递生殖医学

阴道微生物组组成与医学辅助生殖结局:系统综述与网络荟萃分析

Vaginal microbiome composition and medically assisted reproduction outcomes: a systematic review and network meta-analysis of 2289 women across three WHO regions.
PubMed 文献 · Hum Reprod Update · 2026-10-15

与L. crispatus相比,L. jensenii主导型(OR 0.42,95%CI 0.19-0.92)和低乳杆菌群落(OR 0.59,95%CI 0.38-0.91)与妊娠几率显著降低相关,其他乳杆菌无显著差异。证据不足以支持临床常规CST分型。

要点

  • 与L. crispatus相比,L. jensenii主导型和低乳杆菌群落与MAR后妊娠几率降低显著相关。
  • L. gasseri和L. iners等其他乳杆菌与L. crispatus相比无显著差异。
  • 现有证据不足以支持临床实施CST分型,需更大型标准化前瞻研究。

核心结论

  • L. jensenii主导型和低乳杆菌群落CST与MAR后妊娠几率显著低于L. crispatus,其他乳杆菌无显著差异。
  • 不能笼统认为乳杆菌主导CST均对MAR有益,需区分具体乳杆菌 dominance。
  • 现有证据不足以支持CST分型的临床实施。

研究设计与样本

  • 检索PubMed、Embase、Web of Science和Cochrane Library,截至2026年4月2日。
  • 纳入标准:测序法评估胚胎移植或IUI前阴道微生物组并报告MAR后妊娠的纵向研究。

主要发现

  • 与L. crispatus相比,L. jensenii主导型CST妊娠几率显著降低(OR 0.42,95%CI 0.19-0.92)。
  • 与L. crispatus相比,低乳杆菌群落CST妊娠几率显著降低(OR 0.59,95%CI 0.38-0.91)。
  • L. gasseri和L. iners等其他乳杆菌与L. crispatus相比无统计学显著差异。
  • 仅5项研究报告活产,共57例活产,活产证据有限。

关键数值与推荐

  • 网络荟萃分析整合6类CST的直接与间接证据。
  • 主要网络未发现整体或环路不一致性证据。
  • 亚组分析受数据稀疏、不精确性和局部不一致性限制。

临床怎么用

  • 临床不应常规假设所有乳杆菌主导CST均对MAR有益。
  • 目前证据不足以支持临床实施CST分型作为预后工具。
  • 需更大型标准化前瞻纵向研究验证CST分型的预后价值。

局限性

  • 观察性设计、残留混杂、临床与方法学异质性限制解释。
  • 多个CST比较证据稀疏,亚组分析不精确。
  • 活产证据尤其有限,仅5项研究共57例活产。
  • 因效应修饰因素未按CST一致报告,无法正式评估传递性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The vaginal microbiome may influence the success of medically assisted reproduction (MAR), including IVF with or without ICSI, and IUI. However, findings across studies remain inconsistent, and previous meta-analyses have largely relied on binary microbiome classifications or pairwise comparisons. The relative associations between individual vaginal community state types (CSTs) and pregnancy outcomes therefore remain uncertain. OBJECTIVE AND RATIONALE: To compare the associations between individual CSTs and pregnancy following MAR by integrating direct and indirect evidence in a systematic review and network meta-analysis (NMA) and to determine whether specific CSTs were associated with lower odds of pregnancy. SEARCH METHODS: PubMed, Embase, Web of Science, and the Cochrane Library were searched from database inception to 2 April 2026. Eligible longitudinal studies assessed vaginal microbiome composition using sequencing-based profiling before embryo transfer or IUI and reported pregnancy following MAR. Cross-sectional studies, studies without CST classification, or pregnancy outcome data, and studies based solely on post-treatment sampling were excluded. Two reviewers independently performed study selection and risk-of-bias assessment. Odds ratios (ORs) with 95% CIs were synthesized across CSTs using NMA. Twelve longitudinal studies including 2289 women met the inclusion criteria. The prospectively registered review was reported in accordance with PRISMA and the PRISMA extension for NMA. OUTCOMES: The NMA allowed integration of direct and indirect evidence across six CST categories. Compared with Lactobacillus (L.) crispatus, Lactobacillus jensenii-dominated CSTs (OR 0.42, 95% CI 0.19-0.92), and low-lactobacillus community CSTs (OR 0.59, 95% CI 0.38-0.91) were associated with significantly lower odds of pregnancy. No statistically significant differences were observed for other lactobacilli, including Lactobacillus gasseri and Lactobacillus iners, compared with L. crispatus. Tests found no evidence of overall or loop inconsistency in the primary network. Subgroup analyses showed broadly similar patterns but were limited by sparse data, imprecision, and local inconsistency in some subgroup networks. Interpretation was further limited by clinical and methodological heterogeneity, observational study designs, residual confounding, and sparse evidence for several CST comparisons. Live-birth evidence was particularly limited: only five studies reported a total of 57 live births. Transitivity could not be formally assessed because potential effect modifiers were not consistently reported for individual CSTs. WIDER IMPLICATIONS: The findings indicate that general assumption of Lactobacillus-dominated CSTs being beneficial to MAR-treatment effects should be regarded with caution, as these may differ in their associations with pregnancy, depending on the specific Lactobacillus dominance. However, the available evidence is insufficient to support clinical implementation of CST profiling. Larger, standardized prospective longitudinal studies with CST-specific reporting, adjusted estimates, repeated microbiome sampling, and live-birth outcomes are required to determine whether CST profiling has clinically useful prognostic value and whether microbiome-targeted interventions improve reproductive outcomes. REGISTRATION NUMBER: PROSPERO CRD420251066092.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Shabana H, Gudnadottir U, Hugerth LW, et al. Vaginal microbiome composition and medically assisted reproduction outcomes: a systematic review and network meta-analysis of 2289 women across three WHO regions. Hum Reprod Update. 2026. PMID: 42885155. doi:10.1093/humupd/dmag033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。